ResMed
RMD
947 hedge funds and large institutions have $23.4B invested in ResMed in 2025 Q4 according to their latest regulatory filings, with 113 funds opening new positions, 335 increasing their positions, 338 reducing their positions, and 101 closing their positions.
12% more first-time investments, than exits
New positions opened: 113 | Existing positions closed: 101
3.64% more ownership
Funds ownership: 62.79% → 66.43% (+3.6%)
0% less funds holding
Funds holding: 950 → 947 (-3)
1% less repeat investments, than reductions
Existing positions increased: 335 | Existing positions reduced: 338
7% less capital invested
Capital invested by funds: $25.1B → $23.4B (-$1.8B)
44% less funds holding in top 10
Funds holding in top 10: 9 → 5 (-4)
73% less call options, than puts
Call options by funds: $84.1M | Put options by funds: $306M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$274M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$202M |
| 3 |
Morgan Stanley
New York
|
+$148M |
| 4 |
Swedbank
Stockholm,
Sweden
|
+$143M |
| 5 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$89.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$119M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$108M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$85.1M |
| 4 |
Los Angeles Capital Management
Los Angeles,
California
|
-$61.9M |
| 5 |
Barclays
London,
United Kingdom
|
-$56.4M |
RMD Hedge Fund Activity: Q4 2025 in Review
947 of the 8,266 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q4 2025, worth a combined $23.4B — down 7.1% from $25.1B a quarter earlier.
Buyers outnumbered sellers: 113 funds opened new RMD positions and 101 closed out — a net gain of 12 holders — while 335 added to existing stakes and 338 trimmed.
The largest buyer was First Trust Advisors, adding an estimated $274M. The largest seller was Fidelity Investments, cutting an estimated $119M.
- 947 institutional investors held ResMed (RMD) as of Q4 2025, down from 950 in Q3 2025.
- Funds reported $23.4B of ResMed stock for Q4 2025, down 7.1% quarter-over-quarter.
- 113 funds opened new ResMed positions in Q4 2025 and 101 closed out, a net change of +12 holders.
- The largest ResMed buyer in Q4 2025 was First Trust Advisors, an estimated $274M added.
- The largest ResMed seller in Q4 2025 was Fidelity Investments, an estimated $119M sold.
Based on aggregated 13F filings for Q4 2025.